A novel tricyclic polyketide, vanitaracin A, specifically inhibits the entry of hepatitis B and D viruses by targeting sodium taurocholate cotransporting polypeptide
Publication status
publishedExternal links
Journal / series
Journal of VirologyVolume
Pages / Article No.
Publisher
American Society for MicrobiologyNotes
Published online 16 September 2015.More
Show all metadata